Maximus (NYSE:MMS) Shares Up 3.5% - What's Next?

Maximus, Inc. (NYSE:MMS - Get Free Report) rose 3.5% during trading on Tuesday . The stock traded as high as $67.00 and last traded at $66.62. Approximately 133,909 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 466,030 shares. The stock had previously closed at $64.34.

Wall Street Analysts Forecast Growth

MMS has been the subject of a number of recent analyst reports. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Maximus Stock Up 4.8 %

The stock has a market cap of $4.03 billion, a P/E ratio of 15.33 and a beta of 0.71. The business has a 50-day simple moving average of $72.80 and a 200-day simple moving average of $80.41. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Remove Ads

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.68%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Insider Transactions at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Raymond B. Ruddy bought 3,490 shares of the business's stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average price of $71.46 per share, with a total value of $249,395.40. Following the completion of the purchase, the director now directly owns 112,520 shares of the company's stock, valued at $8,040,679.20. This represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 7,008 shares of company stock worth $497,835 over the last three months. 1.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. UMB Bank n.a. raised its stake in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares in the last quarter. V Square Quantitative Management LLC raised its stake in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after acquiring an additional 180 shares in the last quarter. Petrus Trust Company LTA raised its stake in Maximus by 2.7% during the third quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider's stock worth $660,000 after acquiring an additional 185 shares in the last quarter. Hillsdale Investment Management Inc. raised its stake in Maximus by 0.4% during the fourth quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock worth $3,912,000 after acquiring an additional 230 shares in the last quarter. Finally, Holocene Advisors LP raised its stake in Maximus by 6.5% during the third quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider's stock worth $366,000 after acquiring an additional 239 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.